A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension
Clinical trial NCT01518998 · COMPLETED
Trial details
- NCT number
- NCT01518998
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2013-10-01
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.